Analyst Price Targets — VINC
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 8, 2024 9:39 am | Jonathan Chang | Leerink Partners | $2.00 | $0.58 | TheFly | Vincerx Pharma price target lowered to $2 from $4 at Leerink |
| June 7, 2022 2:11 pm | Matthew Barcus | Chardan Capital | $4.00 | $1.98 | Benzinga | Analysts Cuts Price Target On This Small Cap But Remain Bullish |
Latest News for VINC
Contrasting Whitehawk Therapeutics (NASDAQ:WHWK) & Vincerx Pharma (NASDAQ:VINC)
Whitehawk Therapeutics (NASDAQ: WHWK - Get Free Report) and Vincerx Pharma (NASDAQ: VINC - Get Free Report) are both small-cap manufacturing companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership and earnings. Analyst Recommendations This is a breakdown of
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VINC.
U.S. House Trading
No House trades found for VINC.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.